Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients
Table 1
Clinical features concerning the enrolled COVID-19 population.
Variables
Total ()
Age, years
62.79 (11.61)
Sex
Male
109 (66.1)
Female
56 (33.9)
IL-6 levels
0-10 pg/ml
55 (33.3)
10-100 pg/ml
55 (33.3)
>100 pg/ml
55 (33.3)
Days of symptomatology at admission
7.6 (4.0)
Hypertension
66 (44.0)
Dyslipidaemia
53 (32.1)
Diabetes mellitus
33 (20.0)
Charlson Comorbidity Index Score
0.84 (1.42)
ALT (U/l)
40.6 (29.9)
AST (U/l)
51.1 (30.4)
GGT (U/l)
86.7 (95.1)
LDH (U/l)
358.1 (139.4)
CRP (mg/l)
132.8 (143.7)
Leukocytes (counts/μl)
7636 (3564)
NLI
7.9 (7.9)
RDW (%)
13.3 (1.2)
D-Dimer (μg/ml)
1.71 (5.44)
Ferritin (ng/ml)
1065.3 (917.6)
Total cholesterol (mg/dl)
138.8 (34.3)
SBP (mmHg)
137.8 (21.9)
DBP (mmHg)
79.1 (14.1)
Baseline blood glucose (mg/dl)
130.2 (59.1)
BMI (kg/m2)
28.4 (4.6)
Current smoker
11 (7.01)
Standard drink units
3.69 (23.07)
Hospital stay days
14.0 (13.1)
ICU admission
22 (13.3)
Mortality
16 (10.1)
ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: Gamma Glutamyl Transpeptidase; LDH: lactate dehydrogenase; CRP: C-reactive Protein; NLI: Neutrophil/Lymphocyte index; RDW: Red Cell Distribution Width; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; BMI: Body Mass Index; SD: standard deviation. Qualitative variables are expressed in number and proportion. Quantitative variables are expressed in mean and standard deviation.
